HGH Fragment 176-191, also known by the code AOD-9604, is not the whole growth hormone but only a short terminal piece of it. The idea behind its design was simple: take the part of the molecule linked to effects on fat metabolism and discard the rest. Here is how well that idea held up.
What HGH Fragment 176-191 is, briefly
It is a synthetic peptide corresponding to the C-terminal region (amino acids 176-191) of human growth hormone. This region was historically described as the lipolytic domain, the part associated with fat breakdown in experimental models. The mechanistic breakdown is in the HGH Fragment 176-191 monograph.
What the studies showed, honestly
Early work characterized the metabolism of the synthetic lipolytic domain AOD9604 and its effect on lipid metabolism in experimental models (Horm. Res., 2000). The peptide later reached human trials; a 2013 paper assessed its safety and tolerability (J. Endocrinol. Metab., 2013).
Here is an honest detail that is often left out. Despite promising preclinical data, human clinical studies did not confirm a significant effect on body weight compared with placebo. In other words, "fat-loss fragment" is a marketing label, not a conclusion from the evidence. We cite no percentages of "efficacy" because reliable figures of that kind do not exist.
Why researchers find it interesting
The story of AOD9604 is itself a useful example of how a promising preclinical finding fails to translate to humans. As a fragment of a known hormone, it remains a convenient tool for studying which regions of a molecule are responsible for what.
Research status
Longeva material is research use only. It is not a medicine, a supplement, or a weight-loss product. HGH Fragment 176-191 has no approved indications; the data cited concern research work and are not a basis for self-administration. Technical parameters are in the dosing document, not in this text.
Lots come with a certificate of analysis from an independent third-party laboratory; a COA (certificate of analysis) by lot number is in the open archive. For presentation, see the HGH Fragment 176-191 catalogue page.